A. Maternal obesity is associated with ovarian inflammation and upregulation of early growth response factor 1. Am J Physiol Endocrinol Metab 311: E269 -E277, 2016. First published June 7, 2016 doi:10.1152/ajpendo.00524.2015.-Obesity impairs reproductive functions through multiple mechanisms, possibly through disruption of ovarian function. We hypothesized that increased adiposity will lead to a proinflammatory gene signature and upregulation of Egr-1 protein in ovaries from obese (OB; n ϭ 7) compared with lean (LN; n ϭ 10) female Sprague-Dawley rats during the peri-implantation period at 4.5 days postcoitus (dpc). Obesity was induced by overfeeding (40% excess calories for 28 days) via total enteral nutrition prior to mating. OB dams had higher body weight (P Ͻ 0.001), greater fat mass (P Ͻ 0.001), and reduced lean mass (P Ͻ 0.05) and developed metabolic dysfunction with elevated serum lipids, insulin, leptin, and CCL2 (P Ͻ 0.05) compared with LN dams. Microarray analyses identified 284 differentially expressed genes between ovaries from LN vs. OB dams (Ϯ1.3 fold, P Ͻ 0.05). RT-qPCR confirmed a decrease in expression of glucose transporters GLUT4 and GLUT9 and elevation of proinflammatory genes, including CCL2, CXCL10, CXCL11, CCR2, CXCR1, and TNF␣ in ovaries from OB compared with LN (P Ͻ 0.05). Protein levels of PI3K and phosphorylated Akt were significantly decreased (P Ͻ 0.05), whereas nuclear levels of Egr-1 (P Ͻ 0.05) were increased in OB compared with LN ovaries. Moreover, Egr-1 was localized to granulosa cells, with the highest expression in cumulus cells of preovulatory follicles. mRNA expression of VCAN, AURKB, and PLAT (P Ͻ 0.05) correlated with %visceral fat weight (r ϭ 0.51, Ϫ0.77, and Ϫ0.57, respectively, P Յ 0.05), suggesting alterations in ovarian function with obesity. In summary, maternal obesity led to an upregulation of inflammatory genes and Egr-1 expression in peri-implantation ovarian tissue and a concurrent downregulation of GLUTs and Akt and PI3K protein levels.
IN THE US, 60% OF WOMEN OF REPRODUCTIVE AGE are either overweight or obese, which predisposes them to higher risk of infertility and pregnancy complications (12, 21, 57, 59, 60) and potentially leads to adverse effects on offspring development. Higher adiposity leads to hormonal dysregulation, decreased primordial follicle numbers at the initiation of follicular development, lower ovulation rates, a reduced number of cleaved blastocysts developing to eight cell stage and reduced implantation rates, and ultimately impaired reproductive function (11, 16, 17, 22, 33, 35, 61) . Similarly, in experimental models, obesity leads to decreased primordial and preovulatory follicle numbers, increased follicular atresia and changes in steroidogenesis via decreased steroidogenic acute regulatory protein, and increased Cyp11a1 protein content in ovarian tissue (7, 16, 23, 37, 38, 53, 61) . Evidence of lipid accumulation, endoplasmic reticulum stress, and oxidative stress in ovaries from obese dams compared with lean controls may result partially in altered oocyte maturation, increased anovulation, and decreased in vivo fertilization rates (7, 9, 47, 53, 64, 65) .
Although cytokines and macrophages play an important role in regulating cellular proliferation, follicular growth, steroidogenesis, and the activation and recruitment of leukocytes during ovulation and luteinization (10, 37, 51) , low-grade systemic inflammation has been shown to be concurrent with obesity-associated reproductive function problems leading to infertility (34, 37, 38, 40, (42) (43) (44) . Nteeba et al. (38) identified higher immune cell filtration and an upregulation of proinflammatory cytokine/chemokine gene expression in the periovarian adipose tissues as well as proinflammatory and oxidative stress gene expression signatures in the ovaries of mice fed a high fat diet. In addition, genetically modified obese mice, lethal yellow, have increased ovarian proinflammatory protein content through elevation of ovarian nuclear factor-B (NF-B) signaling proteins compared with wild type (37) .
Most studies have used high-fat diets or genetically altered mice and rats to model the obese phenotype characterized by metabolic dysfunction and high levels of adiposity. In the current study, we employed total enteral nutrition (TEN) to induce obesity by controlled overfeeding and to investigate the effects of obesity at the peri-implantation period. This model allows for the study of excess caloric intake without necessitating macronutrient imbalance as a potential confounder. Previous studies using this model have demonstrated a placental and uterine proinflammatory response in obese dams compared with lean controls (49, 55, 58) . Early growth response 1 (Egr-1) was identified as a proinflammatory regulator at the placental level. However, it remains unclear what the effects of caloric excess are on the ovary. This study investigated whether an overfeeding model of obesity is associated with changes in ovarian gene expression during the preimplantation period. Specifically, we examined whether maternal obesity leads to changes in inflammation-related gene expression in the whole ovary. Our data indicate that increased adiposity by overfeeding triggered a proinflammatory gene signature in the ovary and an upregulation of Egr-1 protein content in obese compared with lean dams.
MATERIALS AND METHODS
Experimental design. All experimental procedures were conducted in accordance with the ethics guidelines established and approved by the Institutional Animal Care and Use Committee at the University of Arkansas for Medical Sciences. Virgin female Sprague-Dawley rats (150 -175 g) obtained from Charles River Laboratories (Wilmington, MA) were housed in an Association for Assessment and Accreditation of Laboratory Animal Care-approved facility. Animals were intragastrically cannulated to deliver total enteral nutrition as, described previously (3, 6, 55) . Diets were composed of 75% carbohydrate (dextrose and maltodextrin), 20% protein (casein), and 5% fat (corn oil) as percentage of total kilocalories and met all nutrient recommendations by the National Research Council. Animals were randomized to two groups and received liquid diets at either 155 [lean (LN)] or 220 kcal·kg 3/4 ·day Ϫ1 [40% excess of calories, obese (OB)]. Liquid diets were delivered for 28 days using previously established methods (3, 4, 55) . Caloric intake of 155 kcal·kg 3/4 ·day Ϫ1 mimicked body weights and composition of animals consuming standard commercial chow diet ad libitum. Body weights were monitored three times/wk, and body composition was evaluated using quantitative nuclear magnetic resonance (Echo MRI; Medical Systems, Houston, TX) at the beginning and end of the 28 days of feeding (54) .
LN and OB dams obtained after 4 wk of feeding were bred with lean control males. The presence of sperm in the vaginal lavage was confirmed the following morning to determine successful mating [designated as 0.5 days postcoitus (dpc)]. After mating, all pregnant dams were fed a National Research Council-recommended diet for pregnancy of 220 kcal·kg 3/4 ·day Ϫ1 until dpc 4.5. On dpc 4.5, animals were euthanized via Nembutal anesthesia between 1000 and 1130. Trunk blood was collected and centrifuged to obtain serum, which was stored at Ϫ20°C for metabolic and endocrine assessments. Ovaries were dissected, and surrounding fat tissues were removed and either snap-frozen in liquid nitrogen prior to being stored at Ϫ70°C or placed in buffered formalin for immunohistochemistry analyses.
Serum assays. All serum parameters were measured in LN and OB dams (n ϭ 7 and 10, respectively). Serum glucose (Synermed, Westfield, IN), triglycerides (Cayman Chemicals, Ann Arbor, MI), cholesterol (Synermed), and nonesterified fatty acid (Wako Diagnostics, Richmond, VA) were assessed using commercially available assays. Serum insulin (Linco Research, St. Charles, MO), leptin (Linco), C-reactive protein (Millipore, Billerica, MA), and adiponectin (B-Bridge International, Sunnyvale, CA) were measured using ELISA kits. All assays were completed according to the manufacturers' instructions.
Ovarian mRNA isolation and microarray analyses. Ovarian tissue total RNA was isolated using TRI reagent and purified using a Qiagen RNeasy mini kit, including an on-column DNase digestion (Qiagen, Valencia, CA). For global gene expression of the ovary, three microarrays (GeneChip Rat Genome 230 2.0; Affymetrix, Santa Clara, CA) for each group were performed. Equal amounts of RNA were pooled from two to three dams per microarray. Purified RNA (5 g) was used to synthesize both first-and second-strand cDNA, and double-stranded cDNA was synthesized into labeled cRNA using the GeneChip IVT labeling kit (Affymetrix) according to the manufacturer's protocol. Microarrays were scanned using a GeneChip Scanner 3000 (Affymetrix), and .CEL files were generated using GeneChip Command Console (Affymetrix) (8, 49, 55) . GeneSpring version 11 software (Agilent Technologies, Santa Clara, CA) was used to perform data analyses. Raw data is accessible in the NCBI GEO database (GSE76002). Probe level intensities from .CEL files were processed using robust multiarray analysis algorithm for normalization, background adjustment, and log2-transformation of perfect match values (8, 49, 55) . Genes were filtered based on Ϯ1.3-fold change and P value Յ 0.05 (Student's t-test) between obese and lean dams. Enrichment of biological functions of genes was probed using gene ontology (GO) analyses for biological processes (Gene Spring and GoRilla). Finally, ingenuity pathway analysis and gene set enrichment analysis (GSEA) were utilized to identify top interacting networks and biological processes enriched by maternal obesity. Gene set enrichment analysis does not rely on an arbitrary cutoff, such as fold change between groups, and is a computational method that determines whether an a priori-defined set of genes shows concordant differences and statistical significance between two biological states (8, 49) .
Real-time RT-PCR. Total ovarian RNA (1 g) was reverse-transcribed using the IScript cDNA synthesis kit, and subsequent realtime PCR reactions were performed using the ABI Prism 7500 Fast Sequence Detection System (Applied Biosystems, Foster City, CA) (8, 49, 55) . Gene-specific primers were custom-designed using Primer Express Software (Applied Biosystems) ( Table 1) . A standard curve and normalization to GAPDH mRNA expression were used to quantify the relative amounts of mRNA (8, 49) .
Immunoblotting. Total lysates from whole ovaries (n ϭ 6/group) were prepared in RIPA buffer (25 mM Tris·HCl, 150 mM NaCl, 1.0% NP-40, 1.0% deoxycholic acid, 0.1% SDS, and 2 mM EDTA) containing 1 mM PMSF and protease inhibitors (Sigma Chemicals, St. Louis, MO), and protein quantification was performed using a BCA assay (Pierce, Rockford, IL). Nuclear proteins were isolated from n ϭ 5/group using the EquiQuick Nuclear Extraction kit (Epigentek, Farmingdale, NY) according to the manufacturer's instructions. Western blot analyses were used to determine the protein content for phosphoinositide 3- 
Table 1. Primers sequences for RT-quantitative PCR analyses

Gene
Forward primer (5=-3=) Reverse primer (5=-3=)
Gene-specific primers were designed using Primer Express Software (Applied Biosystems, Foster City, CA). Real-time PCR reactions were carried out according to the manufacturer's instructions for 2ϫ SYBR green master mix and monitored on a ABI Prism 7000 sequence detection system (Applied Biosystems), as described in MATERIALS AND METHODS.
Protein (20 -30 g ) was resolved by a SDS-PAGE gel and probed with primary antibodies overnight in TBST containing either 5% BSA or nonfat milk at 4°C. Membranes were then washed and incubated with horseradish peroxidase-conjugated secondary antibodies (antirabbit or anti-mouse). Following incubation, proteins were visualized using SuperSignal West Pico (Thermo Scientific, Waltham, MA), ECLprime (GE Healthcare Biosciences, Piscataway, NJ), or SuperSignal Femto (Thermo Scientific). Protein densitometric quantification was performed using Quantity One Software (Bio-Rad, Hercules, CA).
Immunohistochemistry and histology. Neutral-buffered, formalinfixed ovaries were embedded in paraffin and cut into 5-m sections. Ovarian sections were first deparaffinized in xylene, hydrated in 100, 80, and 70% ethanol, and rinsed with PBS. Slides were used for immunohistochemistry using the following procedures. Slides were heated with 1ϫ antigen retrieval Citra plus buffer (Life Technologies, Carlsbad, CA) for 12 min and quenched in 3% hydrogen peroxide for 15 min and incubated in blocking solution for 30 min. The primary antibody against Egr-1 (1:200 dilution or PBS for control; Santa Cruz Biotechnology) was applied overnight at 4°. The following morning, slides were incubated with a biotinylated anti-rabbit IgG for 30 min at room temperature and placed in avidin-biotinylated peroxidase complex reagent (Vector Laboratories) for 45 min. The assay was completed with the addition of diaminobenzidine and then counterstained with hematoxylin. Ovarian sections were examined next under an EVOS-FL microscope (Advanced Microscopy Group, Bothell, WA).
Statistical analysis. Data are reported as means Ϯ SE, and statistical significance was determined as P Ͻ 0.05. Real-time RT-PCR results were expressed as mean fold change from lean dams Ϯ SE. Differences between lean and obese dams at dpc 4.5 were determined using two-tailed Student's t-test or Mann-Whitney test for nonparametric analyses. Correlation analyses were conducted using Pearson correlations for linear variables and Spearman correlations for nonlinear variables. Statistical analyses were performed using GraphPad (La Jolla, CA) Prism 6 (version 6.02).
RESULTS
Overfeeding associated with an obesogenic phenotype in dams. As a result of the overfeeding by total enteral nutrition, obese dams were significantly heavier (20% greater) and had greater body fat (30% greater) and significantly lower lean body mass (10% less) compared with lean controls (Table 2) . Fat pad weights (retroperitoneal plus gonadal relative to body weight) were significantly increased in obese compared with lean dams (6.7 Ϯ 0.13 vs. 4.1 Ϯ 0.28%, P Ͻ 0.0001), whereas liver weight as a percent of body weight was similar between the groups (3.9 Ϯ 0.26 vs. 4.1 Ϯ 0.18%, P ϭ 0.48). Obese animals displayed a significant increase in circulating lipids (triglycerides, total cholesterol, and nonesterified fatty acids), insulin, and leptin compared with lean controls (P Ͻ 0.05; Table 2 ). In addition, obese animals displayed systemic inflammation, as demonstrated by increased serum inflammatory markers chemokine (C-C motif) ligand 2 (CCL2; P Ͻ 0.05) and C-reactive protein (CRP; P ϭ 0.08) compared with lean dams (Table 2) . Previous studies using this overfeeding model focused on characterizing maternal obesity effects on the offspring and saw no change in reproductive outcomes, with similar numbers in blastocysts at dpc 4.5, a proportion of successful pregnant dams, and litter sizes at term between the LN and OB groups (54, 55) . This might be due in part to the short period of obesity prior to mating (3-4 wk) relative to longer duration normally employed in high-fat diet-fed mouse studies (8 -12 wk) .
Obesity associated with ovarian inflammation. Microarray analyses were conducted to elucidate the influence of obesity on whole peri-implantation ovarian tissue. Unsupervised global clustering based on maternal phenotype suggested a significant effect of obesity on ovarian global gene expression. A total of 284 transcripts were differentially expressed between obese and lean dams (Ϯ1.3-fold, P Ͻ 0.05). GO analyses clustered the differentially expressed genes into the following biological processes: cellular component movement; microtubule-based process; cilium movement, biological adhesion; cell adhesion; axonemal dynein complex assembly; microtubule-based movement; leukocyte migration involved in inflammatory response; epithelial cilium movement; and positive regulation of leukocyte migration (Table 3) .
Consistent with GO term enrichment, hierarchical clustering of genes in the chemokine signaling pathway was differentially expressed between lean and obese dams (Fig. 1A) . These results were confirmed using quantitative RT-PCR of ovarian mRNA for 7 proinflammatory genes (Fig. 1B) . Ovarian mRNA expression of obese dams was significantly increased for CCL2 (ϳ2.4-fold), chemokine (C-X-C motif) ligand 10 (ϳ2.0-fold), CXCL11 (ϳ3.0-fold), chemokine (C-C motif) receptor 2 (ϳ1.5-fold), chemokine (C-X-C motif) receptor 1 (ϳ3.5-fold), and tumor necrosis factor-␣ (TNF␣; ϳ1.4-fold) genes compared with lean dams.
Ovarian inflammation is associated with a downregulation of insulin signaling and an upregulation of nuclear Egr-1 expression. Microarray results demonstrated that both glucose transporter (GLUT)4 and GLUT9 mRNA expression were downregulated in obese compared with lean dams, which was confirmed by quantitative RT-PCR (P Ͻ 0.05; Fig. 2A) . Moreover, insulin-signaling protein content of PI3K and p-Akt/Akt in total ovarian lysates was significantly decreased in obese dams compared with lean dams (P Ͻ 0.05; Fig. 2B ).
To explore whether Egr-1 signaling was associated with the ovarian proinflammatory response, immunoblotting and immunohistochemistry were performed. Results demonstrated an upregulation of whole ovary nuclear Egr-1 protein levels in obese compared with lean dams (P Ͻ 0.05; Fig. 2C ). Immunohistochemistry analyses revealed that Egr-1 was localized to granulosa cells and particularly enriched in the cumulus cells Data were collected at 4.5 days postcoitus (dpc) and are expressed as means Ϯ SE. NEFA, nonesterified fatty acids; CCL2, chemokine (C-C motif) ligand 2. NEFA, leptin, insulin, glucose, adiponectin, CCL2, and C-reactive protein were measured in serum. Differences between groups were determined by using Student's t-test, with a statistical significance level of P Ͻ 0.05. of antral and preovulatory follicles (Fig. 3) , which may explain why the whole ovary nuclear Egr-1, which contains multiple cell types, was only increased 1.5-fold.
Obesity associated with changes in gene expression for markers of ovarian function. Previous reports have suggested that maternal obesity may be detrimental to ovarian function by decreasing follicle numbers, increasing follicular atresia, and altering steroidogenesis. Results from the GO analyses for biological processes identified key ovarian genes that were differentially expressed between lean and obese dams. The expression of three key genes was evaluated using quantitative RT-PCR and correlation analyses with visceral fat. Results demonstrated a significant increase in Versican gene expression [VCAN; an extracellular matrix component that mediates functional properties of the granulosa layer throughout folliculogenesis and is required to ensure cumulus expansion and oocyte maturation (48) ], a significant decrease in Aurora kinase B gene expression [AURKB; which ensures chromosome-microtuble interaction and chromosome segregation (5, 52, 56)], and a significant decrease in tissue plasminogen activator gene expression [PLAT; which prevents blood clotting of the follicular wall and thereby prevents entrapment of the cumulus oocyte complex during ovulation (25) , all of which were found to correlate with percentage visceral fat weights, P Յ 0.05] (Fig. 4) . Fig. 1 . Upregulation of the chemokine signaling pathway in ovarian tissue of obese dams. A: microarray analyses from ovarian mRNA collected at 4.5 days postcoitus (dpc) identified 284 genes that were differentially expressed in obese dams when filtered at a Ϯ1.3 fold change and significance level of P Ͻ 0.05. Red and blue indicate high and low expression, respectively. B: quantitative RT-PCR on whole ovarian tissue was assessed to confirm a small subset of proinflammatory genes from the heat map (n ϭ 10/lean and n ϭ 7/obese). All values were normalized to GAPDH mRNA expression as mean fold change relative to the lean group. Data are expressed as means Ϯ SE. *P ϭ 0.05. CCL2, chemokine (C-C motif) ligand 2; CXCL10 and -11, chemokine (C-X-C motif) ligand 10 and -11, respectively; CCR2, chemokine (C-C motif) receptor 2; CXCR1, chemokine (C-X-C motif) receptor 1. GO, gene ontology. Gene expression was assessed in lean and obese dam ovaries at dpc 4.5 using Rat Genome 230 2.0 microarrays (Affymetrix). Enriched GO terms calculated using the GoRilla analyses program among the 284 transcripts differentially expressed between lean and obese are presented above.
DISCUSSION
Inflammation and immune cell-facilitated tissue remodeling play an important role in normal reproductive processes such as menstruation, ovulation, implantation, and parturition (20) . Nonetheless, if inflammatory signals are not tightly regulated, inflammation may be exacerbated within the reproductive organs, such as the ovary, leading to disease development (20) . Obesity is characterized by a subclinical chronic inflammatory response that is seen both systemically and localized within tissues, as illustrated by an increase in inflammatory cytokine expression and immune cell infiltration (13, 26 ). Yet there is limited research exploring the impact of obesity on the inflammatory state in the ovary and how activation of inflammatory pathways could lead to ovarian dysfunction (37, 38) . The present study provides new insights on the effects of obesity induced by overfeeding prior to conception on the ovary during the peri-implantation period. Results demonstrated that overfeeding induces 1) a proinflammatory ovarian response, 2) decreased gene expression of ovarian glucose transporters and reduced phosphorylation state of insulin-activated second-messenger systems, 3) alteration of ovarian function gene expression, and 4) upregulation of Egr-1 protein levels that were specifically localized to the granulosa cells.
A unique aspect of this study is the overconsumption of calories delivered by TEN feeding to induce obesity. This approach maintains similar macronutrient ratios across groups and leads to an increase in adiposity (body weight, fat mass, and visceral fat weight) and metabolic dysregulation similar to that of human obesity, such as hyperlipidemia, hyperinsulinemia, and hyperleptinemia, while maintaining normal glucose levels. Using this same overfeeding model, we have previously reported obesity-induced insulin resistance in dams prior to mating. Obese dams displayed impaired glucose disposal and exaggerated insulin response at all points in time during an oral glucose tolerance test (54) . Importantly, similarly to the current study, these dams showed fasting hyperinsulinemia without changes in serum glucose at baseline. Obese animals also present with a systemic proinflammatory signature.
At the level of the ovary, obesity was associated with differential expression of 284 genes within the chemokine Fig. 2 . Downregulation of insulin signaling and an upregulation of nuclear early growth response 1 (Egr-1) expression. A: quantitative RT-PCR of glucose transporter (GLUT)4 and GLUT9 normalized to GAPDH from whole ovarian tissue from dpc 4.5 of lean and obese dams (n ϭ 10/lean and n ϭ 7/obese, means Ϯ SE). All values were normalized to GAPDH mRNA expression as mean fold change relative to the lean group. B: Western blot of total cell ovarian lysates and densitometric analyses of phosphatidylinositol 3-kinase (PI3K) and p-Akt/Akt normalized to ␣-tubulin for lean and obese dams (n ϭ 6/group, means Ϯ SE). C: Western blot of ovarian nuclear lysates and densitometric analyses of Egr-1 normalized to TATA-binding protein for lean and obese dams (n ϭ 5/group, means Ϯ SE). *P Ͻ 0.05. signaling pathway, insulin-signaling pathway, and ovarian function system compared with lean dams. Confirmation by RT-qPCR analyses showed a significant increase in chemokines, chemokine receptors, and cytokine gene expression in obese dams. These data are in line with previous published results by Nteeba et al. (38) , who found an increase in ovarian gene expression of inflammatory markers CCL2 and TNF␣ and receptors of the TNF␣ signaling pathway (p55 and p75) in Fig. 3 . Cellular localization of Egr-1 protein in ovarian granulosa and cumulus cells. Representative images of paraffin sections from ovaries isolated on dpc 4.5 immunostained for Egr-1 (brown stain) and counterstained with hematoxylin (purple). Note the greater levels of Egr-1 localized in granulosa and cumulus cells of ovarian antral and preovulatory follicles [negative control (no primary antibody; A and B), lean dams (C-E), and obese dams (F-H); A, B, C, D , F, and G: ϫ20 magnification; E and H: ϫ40 magnification]. Arrows point out the cumulus cells of preovulatory follicles. Fig. 4 . mRNA expression of ovarian function genes is associated with visceral adiposity. A: ovarian gene expression (RT-quantitative PCR) of genes associated with ovarian function: versican (VCAN), Aurora kinase-␤ (AURK␤), and tissue plasminogen activator (PLAT) (n ϭ 7-10/group; means Ϯ SE, *P ϭ 0.05). All values were normalized to GAPDH mRNA expression as mean fold change relative to the lean group. B-D: correlation analyses of ovarian mRNA gene expression levels, with %visceral fat weight (retriperitoneal ϩ gondal fat pads) in each dam.
obese mice fed a high-fat diet for 7 mo (37). In addition, obesity induced by genetic modification (lethal yellow mice) has demonstrated changes in NF-B pathway-related proteins in whole ovarian tissue, with a significant increase in IB protein content at 12 and 24 wk of age and increased phosphorylated NF-B p65 content at 12 wk of age compared with control littermates (37) .
Previous studies using obese models have shown increased inflammation to be associated with changes in glucose metabolism (41, 67) . In this study, obesity was also associated with a downregulation of ovarian glucose transporter gene expression (GLUT4 and GLUT9) compared with lean controls. GLUT4 is expressed in different follicle types, including the corpus luteum (36, 62, 63, 68) , whereas GLUT9 is expressed on the surface of cumulus cells (45) . Animals in this study showed no change in systemic blood glucose levels despite a decrease in ovarian GLUT expression. This is not surprising, as physiologically the majority of glucose disposal occurs in the skeletal muscle and liver and not the ovary. The functional consequences of changes in GLUT expression in the ovary still remain unclear. Recent studies have shown that glucose transporters have been found in cumulus cells and function as the mediator of glucose uptake. In mouse inhibition of specific GLUTs, that leads to a decreased uptake of glucose in both the cumulus and oocyte (63) . Our results are in line with a study by Kim et al. (24) that also demonstrated a downregulation of both GLUT4 and GLUT9 expression in human granulosa cells from patients with polycystic ovarian syndrome who were insulin resistant. It is possible that increased glucose uptake in specific cell types in the ovaries associated with an established mitochondrial dysfunction present in obesity has been shown to lead to generation of ROS contributing to proinflammatory processes (18, 31, 47) . This could present a link between impaired metabolism in obese ovaries and inflammation.
Emerging evidence has suggested that Egr-1 may be driving the inflammatory response within adipose and muscle tissue (15, 69) and has been identified as mediator of inflammation in reproductive tissues (49, 58) . Indeed, Egr-1 protein was increased in human placenta from obese women compared with normal-weight women (49) . Using CHIP analyses, Egr-1 was shown to lead to an upregulation of TNF␣, IL-6, and IL-8 expression in an in vitro model of BeWo placenta cells (49) . These results suggest that Egr-1 may mediate placental inflammation seen in obese women. Interestingly, Egr-1 gene expression in umbilical cord tissue was also significantly and positively associated with maternal adiposity (58) . In this study, PI3K and p-Akt/Akt protein content were significantly lower in ovarian total lysates, whereas Egr-1 protein level was upregulated in ovarian nuclear lysates of obese dams compared with lean dams. Localization of Egr-1 was specific to the cumulus type of granulosa cells of antral and preovulatory follicles. Egr-1 has previously been shown to play a key regulatory role in the ovulation process and localized to granulosa cells of preovulatory and antral follicles after human chorionic gonadotropin stimulation in normal-weight rats (14) . Prior studies by Akamine et al. (2) and Nteeba et al. (39) established that long exposure to high-fat diet in both rats and mice can lead to a similar reduction in PI3K and Akt phosphorylation in whole ovarian tissue, as seen in the current study compared with lean controls. Results from the present study demonstrate that insulin signaling may be affected by obesity; however, additional studies leveraging insulin challenges or hyperinsulinemic euglycemic clamps are warranted to confirm whether ovaries are insulin resistant in this model (2, 66) . Studies using primary granulosa cell cultures are also needed to test whether the decrease in PI3K and p-Akt leads to this upregulation of Egr-1. Disruption in the PI3K/Akt signaling pathway can also have detrimental implications for ovarian function via changes in follicular recruitment, development, and survival (1, 27, 39, 46, 70) ; thus, more experiments are needed to make these connections within this model.
With our overfeeding paradigm, gene expression of key ovarian function markers (VCAN, AURKB, and PLAT) was shown to differ in ovarian tissues of obese dams compared with lean dams. VCAN, an extracellular matrix component that mediates functional properties of the granulosa layer throughout folliculogenesis, which is required to ensure cumulus expansion and oocyte maturation, was increased in obese dams. Previous research demonstrated an increased expression of VCAN in patients with diminished ovarian reserve, which is associated with obesity, compared with normal patients (32) . AURKB, which plays a critical role in chromosome-microtuble interaction and ensures chromosome segregation, was downregulated in obese dams. Inhibition of AURKB leads to low oocyte development competence and increased aneuploidy, which can in turn increase fertility challenges (5, 30, 50, 56) . However, to date no study has linked obesity with AURKB gene expression within the ovarian tissue. PLAT, which prevents blood clotting of the follicular wall and thereby stops entrapment of the cumulus-oocyte complex during ovulation, was decreased in obese dams. This gene has been shown to play a role only in normal ovarian function (28, 29) , yet there is a lack of evidence linking obesity-induced effects to regulation of this gene within the ovary. Together, these results demonstrate that obesity induced by overconsumption of calories leads to changes in key ovarian gene expression that may impact follicular development, ovulation, and oocyte maturation compared with lean dams.
This current study is not without limitations. First, ovarian samples were collected during the peri-implantation period (dpc 4.5), which meant that the ovary was in a progesteronedependent state compared with a more estrogen-dependent state that is seen prior to ovulation during normal cycling. We chose dpc 4.5 in part to determine whether the changes we observed previously in the uterus and male blastocyst (55) at this time point were also associated with changes in the ovary. Recent evidence found that germline effects in the oocyte due to maternal obesity were sufficient to lead to programming in the offspring when using in vitro fertilization (19) , suggesting that the programmed effects in the embryo and later offspring might in fact be due to alterations in the ovarian environment. Nonetheless, understanding the status of ovarian changes in a nonpregnant state is highly relevant and is being addressed in a followup study. However, since both groups were exposed to similar conditions within this experimental paradigm, results should reflect the effects of obesity under these conditions. Second, whole ovary tissue samples were used to determine changes in the ovarian transcriptome due to obesity that include multiple cell types; therefore, changes to specific ovarian cells may have been underestimated. Third, the exact mechanisms whereby obesity leads to an ovarian proinflammatory environment and an upregulation of Egr-1 have yet to be investigated with the use of ovarian primary cell cultures. Finally, the experimental design of the present study does not allow for dissociating whether the ovarian proinflammatory response identified herein is a direct consequence of overfeeding or due to indirect effects of obesity-induced altered folliculogenesis. Unlike previous research (2, 37, 38), we did not see changes in folliculogenesis or fertility with our feeding approach, suggesting that overfeeding may be acting as a more direct influence. Nonetheless, more studies would be needed to determine this unequivocally.
In conclusion, the present study has used a unique overfeeding model to induce obesity in rat dams by excess consumption of an otherwise well-balanced diet. Results demonstrated that obesity is causing a proinflammatory ovarian response, decreased GLUT4 and GLUT9 mRNA expression, decreased PI3K and p-Akt protein levels, activation of the Egr-1 in granulosa cells, and modulation of follicular development and ovulatory gene expression. Future studies are needed to understand the role of Egr-1 activation in specific ovarian cell types and the mechanisms by which increased adiposity leads to a proinflammatory response within the ovary. Such studies would help to provide insight into the impact obesity has on different ovarian pathological disorders and how maternal obesity potentially influences oocyte, fetal, and/or offspring development.
